rais adjust ep estim
consensu
expect respect see combin price increas
coopervis recent bp fed rate cut favor currenc
movement particularli yen increment posit coo
earn outlook note coo prior interest expens guidanc
million assum addit fed rate increas cut year
regard contact len price research suggest coopervis rais
 price roughli juli increas spread fairli broadli
among newer legaci product note coopervis second
 price increas year follow typic small adjust
januari legaci product help incentiv patient switch newer
offer view coopervis juli price increas surpris
follow above-norm contact len price increas alcon
earlier year think provid modest upsid compani
guidanc benefit manag told us
late may unsur whether would rais price year
moreov assum reinvest roughli half ep benefit
 price increas sale market initi effort help
compani continu drive sustain growth market rate
rais fiscal coopervis america
organ growth forecast respect reflect
recent price increas beyond price move research
model organ growth world-wide contact
len market includ coopervis fiscal
signific contributor increas adjust ep
estim currenc movement fiscal see currenc chang
modest posit rel coo guidanc revenu benefit
 dollar weaken rel japanes yen offset
impact dollar strengthen rel british pound
weaken british pound also aid cog
standpoint given coopervis inventori day manufactur exposur
total debt total asset
increment posit coo outlook
adjust estim accordingli moreov remain encourag
coopervis decis invest grow key larg retail buy group
account segment point strength think invest along
misight myopia control opportun help provid path toward
continu sustain above-market organ growth divis
maintain buy rate rais price target
import pleas read disclosur disclaim page report
cooper compani inc annual incom statement analysi adjust northcoast research thousand except percent per share gross gross sg sg oper oper net interest interest incom incom incom incom tax minor net incom extra net margin extra extra net net wghd com share ep ep revenu growth adjust ep growth began exclud amort intang adjust ep follow sauflon acquisitionsourc compani report northcoast research estim disclosur
